Sees cash flow “way over” $3B in 2030. Comments taken from the Evercore ISI 8th Annual HealthCONx Conference.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TEVA:
- Trump Weekly: White House postpones healthcare proposal after backlash
- Trump Trade: Trump says ‘tremendous progress’ on ending Ukrainian war
- JPMorgan views Medicare price cuts as inline with expectations
- Teva receives EC approvals for PONLIMSI, DEGEVMA
- Teva, Amgen, Rithm, Fastly, Medtronic: Major Stock Moves!